Showing results (5271-5280 of 10,388) with videos related to
Sort By:
Pageof 1,039
Vaccines|May 2, 2020
Systemic Sclerosis and Vaccinations: A Register-Based Cohort Study about Seasonal Influenza and Streptococcus pneumoniae Vaccination Rate and Uptake from Liguria Regional Center, Northwest ItalyGiuseppe Murdaca, Giovanni Noberasco, Alberto Battaglini, et al.Vaccines|May 15, 2020
Targeting Host Innate and Adaptive Immunity to Achieve the Functional Cure of Chronic Hepatitis BSayeh Ezzikouri, Mohammad Enamul Hoque Kayesh, Soumaya Benjelloun, et al.Vaccines|April 25, 2020
The Impact of Locoregional Treatment on Response to Nivolumab in Advanced Platinum Refractory Head and Neck Cancer: The Need TrialAndrea Botticelli, Silvia Mezi, Giulia Pomati, et al.Vaccines|April 25, 2020
In Ovo Delivered Toll-Like Receptor 7 Ligand, Resiquimod Enhances Host Responses against Infectious Bronchitis Corona Virus (IBV) InfectionUpasama De Silva Senapathi, Mohamed Aboelkhair, Kekungu Puro, et al.Vaccines|April 11, 2020
Immunogenicity and Efficacy of a Recombinant Human Adenovirus Type 5 Vaccine against Zika VirusTara Steffen, Mariah Hassert, Stella G Hoft, et al.Vaccines|April 17, 2020
Synthetic Peptides Containing Three Neutralizing Epitopes of Genotype 4 Swine Hepatitis E Virus ORF2 induced Protection against Swine HEV Infection in RabbitYiyang Chen, Tianxiang Chen, Yuhang Luo, et al.Vaccines|April 17, 2020
Eliminating Cervical Cancer in Mali and Senegal, Two Sub-Saharan Countries: Insights and Optimizing SolutionsAzizul Haque, Bourèma Kouriba, N'diaye Aïssatou, et al.Vaccines|April 29, 2020
Human Cytomegalovirus Congenital (cCMV) Infection Following Primary and Nonprimary Maternal Infection: Perspectives of Prevention through Vaccine DevelopmentGiuseppe Gerna, Daniele LilleriVaccines|August 6, 2021
High Prevalence of Anti-PF4 Antibodies Following ChAdOx1 nCov-19 (AZD1222) Vaccination Even in the Absence of Thrombotic EventsEvangelos Terpos, Marianna Politou, Ioannis Ntanasis-Stathopoulos, et al.Vaccines|August 6, 2021
Evaluation of Protective Efficacy of Influenza Virus Like Particles Prepared from H5N1 Virus of Clade 2.2.1.2 in ChickensMohamed H El-Husseiny, Naglaa M Hagag, Peter Pushko, et al.Pageof 1,039